MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Lalla, R.; Bowen, J.; Barasch, A.; S. Elting, Linda; Epstein, J.; M. K. Keefe, Dorothy; B. McGuire, Deborah; Migliorati, Cesar; Nicolatou‐Galitis, O.; E. Peterson, Douglas; Raber-Durlacher, J.; T Sonis, Stephen; Elad, S.

doi:10.1002/cncr.28592

Public

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Shared by NobleBlocks on Feb 25, 2014 • 12:00 AM UTC

Authors:

R. Lalla

J. Bowen

A. Barasch

Abstract

Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis.

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!